Table 1.
Overview of baseline demographic and clinical characteristics.
| Variable | COVID + Patients (n = 57 Patients) |
Control Patients (n = 74 Patients) |
p Value |
|---|---|---|---|
| Baseline characteristics | |||
| Age (years) | 64 (40–89) | 64 (41–88) | 0.860 |
| Male | 49 (85.96%) | 64 (86.48%) | 0.564 |
| Urban area | 34 (59.64%) | 44 (59.45%) | 0.563 |
| Admission complaints | |||
| Chest pain | 43 (75.43%) | 57 (77.02%) | 0.496 |
| Dyspnea | 47 (82.43%) | 46 (61.41%) | 0.048 |
| Medical history | |||
| Prior MI | 9 (15.78%) | 25 (33.78%) | 0.016 |
| Prior PCI | 6 (10.52%) | 11 (14.86%) | 0.595 |
| Prior CABG | 2 (3.51%) | 3 (4.05%) | 0.622 |
| Risk factors | |||
| Diabetes mellitus | 30 (52.70%) | 33 (44.59%) | 0.567 |
| Hypertension | 32 (56.14%) | 44 (59.45%) | 0.419 |
| Obesity | 29 (50.87%) | 34 (45.94%) | 0.289 |
| BMI (kg/m2) | |||
| <18 | 6 (10.52%) | 7 (9.45%) | |
| 18–30 | 22 (38.59%) | 33 (44.59%) | |
| 30–40 | 25 (43.85%) | 31 (41.80%) | |
| >40 | 4 (7.14%) | 3 (4.05%) | |
| Dyslipidemia | 19 (33.33%) | 25 (33.78%) | 0.476 |
| Chronic kidney disease | 2 (3.50%) (≥G3a) | 2 (2.70%) (≥G3a) | 0.129 |
| Active smoker | 16 (28.07%) | 20 (27.02%) | 0.872 |
| Admission hemodynamics | |||
| SBP (mmHg) | 132 (88–145) | 145 (120–174) | NA |
| HR (bpm) | 67 (35–87) | 78 (56–112) | NA |
| Oxygen saturation aa (%) | 92% (81–100) | 97% (92–100) | 0.018 |
| Total ischemia time | |||
| <6 h | 5 (8.77%) | 13 (17.56%) | 0.016 |
| 6–12 h | 41 (71.94%) | 54 (72.98%) | 0.563 |
| >12 h | 11 (19.29%) | 7 (9.46%) | 0.024 |
| Killip Class | |||
| I | 46 (80.71%) | 66 (89.19%) | 0.187 |
| II | 3 (5.26%) | 4 (5.40%) | 0.406 |
| III | 2 (3.51%) | 1 (1.36%) | 0.281 |
| IV | 6 (10.52%) | 3 (4.05%) | 0.012 |
aa, atmospheric air; BMI, body mass index; CABG, coronary artery bypass graft surgery; HR, heart rate; MI, myocardial infarction; PCI, percutaneous coronary intervention; SBP, systolic blood pressure.